Speaker illustration

Doctor Hideki Wada

Juntendo University Shizuoka Hospital, Izunokuni (Japan)

Antithrombotic and proton pump inhibitor co-therapy in patients with atrial fibrillation and stable coronary disease: a post hoc analysis of the AFIRE trial

Event: ESC Congress 2022

Topic: Pharmacotherapy

Session: Platelets and more

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb